Oxidative stress: therapeutic approaches for cervical cancer treatment

被引:5
作者
Fernandes Silva, Gabriela Avila [1 ,2 ]
Lima Nunes, Rafaella Almeida [1 ,2 ]
Morale, Mirian Galliote [1 ,2 ]
Boccardo, Enrique [3 ]
Aguayo, Francisco [4 ,5 ]
Termini, Lara [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Canc Estado Sao Paulo ICESP,Ctr Invest Trans, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med FMUSP, Dept Radiol & Oncol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Oncovirol, Sao Paulo, SP, Brazil
[4] Univ Chile, Fac Med, Ctr Avanzado Enfermedades Cron ACCDiS, Santiago, Chile
[5] Univ Chile, Fac Med, Dept Oncol Bas Clin, Santiago, Chile
关键词
Tumor Markers; Human Papillomavirus; Redox System; Cervical Cancer; NF-KAPPA-B; MANGANESE SUPEROXIDE-DISMUTASE; TARGETING RADIOSENSITIZATION TREATMENT; CISPLATIN-INDUCED NEPHROTOXICITY; RADICAL SCAVENGING ABILITY; HUMAN-PAPILLOMAVIRUS; GREEN TEA; IN-VIVO; CURCUMIN DIFERULOYLMETHANE; INTRAEPITHELIAL NEOPLASIA;
D O I
10.6061/clinics/2018/e548s
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Oxidative stress results from an imbalance between the generation and elimination of oxidant species. This condition may result in DNA, RNA and protein damage, leading to the accumulation of genetic alterations that can favor malignant transformation. Persistent infection with high-risk human papillomavirus types is associated with inflammatory responses and reactive oxygen species production. In this context, oxidative stress, chronic inflammation and high-risk human papillomavirus can act in a synergistic manner. To counteract the harmful effects of oxidant species, protective molecules, known as antioxidant defenses, are produced by cells to maintain redox homeostasis. In recent years, the use of natural antioxidants as therapeutic strategies for cancer treatment has attracted the attention of the scientific community. This review discusses specific molecules and mechanisms that can act against or together with oxidative stress, presenting alternatives for cervical cancer prevention and treatment.
引用
收藏
页数:10
相关论文
共 173 条
[1]   Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries [J].
Abdel-Aziz, Amal Kamal ;
Shouman, Samia ;
El-Demerdash, Ebtehal ;
Elgendy, Mohamed ;
Abdel-Naim, Ashraf B. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 217 :28-40
[2]   Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice [J].
Aggarwal, BB ;
Shishodia, S ;
Takada, Y ;
Banerjee, S ;
Newman, RA ;
Bueso-Ramos, CE ;
Price, JE .
CLINICAL CANCER RESEARCH, 2005, 11 (20) :7490-7498
[3]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[4]   Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling [J].
Aggarwal, S ;
Takada, Y ;
Singh, S ;
Myers, JN ;
Aggarwal, BB .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) :679-692
[5]   Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].
Aggarwal, S ;
Ichikawa, H ;
Takada, Y ;
Sandur, SK ;
Shishodia, S ;
Aggarwal, BB .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206
[6]   Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate [J].
Ahmad, N ;
Cheng, PY ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :328-334
[7]   Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions [J].
Ahn, WS ;
Yoo, J ;
Huh, SW ;
Kim, CK ;
Lee, JM ;
Namkoong, SE ;
Bae, SM ;
Lee, IP .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (05) :383-390
[8]   A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G1 arrest, and regulation of gene expression [J].
Ahn, WS ;
Huh, SW ;
Bae, SM ;
Lee, IP ;
Lee, JM ;
Namkoong, SE ;
Kim, CK ;
Sin, JI .
DNA AND CELL BIOLOGY, 2003, 22 (03) :217-224
[9]   PHARMACOLOGY OF CURCUMA-LONGA [J].
AMMON, HPT ;
WAHL, MA .
PLANTA MEDICA, 1991, 57 (01) :1-7
[10]  
[Anonymous], 2013, GLOBOCAN 2012 V1 0 C